RUBICON RESEARCH Company Profile
✉ Email this page to a colleague
What is the competitive landscape for RUBICON RESEARCH
RUBICON RESEARCH has seventy-five approved drugs.
Summary for RUBICON RESEARCH
| US Patents: | 0 |
| Tradenames: | 61 |
| Ingredients: | 60 |
| NDAs: | 75 |
Drugs and US Patents for RUBICON RESEARCH
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rubicon Research | BUSPIRONE HYDROCHLORIDE | buspirone hydrochloride | TABLET;ORAL | 075521-001 | Apr 5, 2002 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Rubicon Research | LOPRESSOR | metoprolol tartrate | SOLUTION;ORAL | 219373-001 | Apr 10, 2025 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Rubicon Research | CYCLOBENZAPRINE HYDROCHLORIDE | cyclobenzaprine hydrochloride | TABLET;ORAL | 208170-003 | May 31, 2017 | AB | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
